《半日速報》恆指半日收報20,267點 跌129點; 恆生科技指數半日收報4,024點 跌74點 阿里巴巴跌逾3% 中信股份、同仁堂國藥、中鐵、中國鐵建、環球醫療創新高
恆指半日收20,267點,跌129點或0.6%。恆生科技指數報4,024點,跌74點或1.8%。國指跌56點或0.8%,報6,838點。
活躍重磅股表現:
阿里巴巴(09988.HK) 收88.95元,下跌3.1%;
平安(02318.HK) 收53.35元,下跌2.8%;
騰訊(00700.HK) 收352元,下跌1.4%;
港交所(00388.HK) 收335.6元,下跌0.8%;
友邦(01299.HK) 收83.4元,下跌0.4%;
美團(03690.HK) 收140.5元,上升0.1%;
建行(00939.HK) 收5.32元,無升跌;
異動恆指及國指成份股:
商湯-W(00020.HK) 收2.54元,下跌7%;
中芯(00981.HK) 收24.15元,下跌5.7%;
阿里健康(00241.HK) 收5.51元,下跌3.8%;
中國宏橋(01378.HK) 收8.22元,下跌3.7%;
李寧(02331.HK) 收59.25元,上升3.2%;
碧桂園服務(06098.HK) 收13.44元,下跌3.2%;
中信股份(00267.HK) 收9.83元,上升1.7%,創新高;
異動綜合中小型股:
同仁堂國藥(03613.HK) 收16.04元,上升3.4%,創新高;
中鐵(00390.HK) 收5.9元,上升1.4%,創新高;
中國鐵建(01186.HK) 收6.64元,上升0.9%,創新高;
環球醫療(02666.HK) 收5.19元,上升0.8%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.